Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28717807)

Published in J Nutr Health Aging on January 01, 2017

Authors

A E Millen1, J Nie, M W Sahli, J A Mares, K J Meyers, B E K Klein, M J LaMonte, P L Lutsey, C A Andrews, R Klein

Author Affiliations

1: Amy E. Millen, Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, The State University of New York, 270 Farber Hall, Buffalo, NY 14214-8001. Telephone: (716) 829-5377, Fax: (716) 829-2979, aemillen@buffalo.edu.

Articles cited by this

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37

A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr (1982) 17.28

Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 11.37

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57

Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37

The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol (2001) 4.50

Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr (2003) 3.04

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol (2004) 2.73

Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol (2010) 2.66

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2010) 2.28

Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity. Int J Epidemiol (1995) 2.00

Validity and repeatability of a modified Baecke questionnaire on physical activity. Int J Epidemiol (1995) 1.89

Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology (2011) 1.81

Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr (2010) 1.67

Role of vitamin D in blood pressure homeostasis. Am J Ther (2010) 1.54

Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr (2012) 1.40

Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum (2010) 1.39

Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol (1999) 1.32

Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol (2007) 1.28

Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS One (2013) 1.16

Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci (2007) 1.15

Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol (2011) 1.13

Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics (2011) 1.08

Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2012) 1.08

Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye (Lond) (2011) 0.92

Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative Korean population. Invest Ophthalmol Vis Sci (2014) 0.90

Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc (2012) 0.89

Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration. Retina (2014) 0.84

The role of inflammation and infection in age-related macular degeneration. Int Ophthalmol Clin (2007) 0.82

Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost (2014) 0.81

Association of vitamin D deficiency and age-related macular degeneration in medicare beneficiaries. Arch Ophthalmol (2012) 0.81

The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One (2013) 0.81

Association Between Vitamin D Status and Age-Related Macular Degeneration by Genetic Risk. JAMA Ophthalmol (2015) 0.78

Vitamin D Deficiency in Community-Dwelling Elderly Is Not Associated with Age-Related Macular Degeneration. J Nutr (2015) 0.77

Articles by these authors

(truncated to the top 100)

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol (1994) 22.96

On the Oregon trail: rationing health care. BMJ (1991) 20.63

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet (1999) 11.79

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28

Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care (1992) 7.69

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68

Milburn's vision of a new NHS. Adopting the missionary position. BMJ (2001) 7.31

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54

Two views on the Griffiths report. The mobilisation of consent versus the management of conflict: decoding the Griffiths report. Br Med J (Clin Res Ed) (1983) 6.16

Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology (1999) 6.07

Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol (1998) 6.04

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91

Explaining outputs of primary health care: population and practice factors. BMJ (1991) 5.61

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (1995) 5.51

Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology (1992) 5.35

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev (1999) 4.75

Variations in budgets of fundholding practices. BMJ (1991) 4.71

Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron (2001) 4.62

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46

Essential role for TrkB receptors in hippocampus-mediated learning. Neuron (1999) 4.20

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08

Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94

Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA (1998) 3.86

Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol (1998) 3.75

Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (1994) 3.73

Equity and the NHS: self-reported morbidity, access, and primary care. Br Med J (1980) 3.72

Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology (1990) 3.66

Visual impairment in diabetes. Ophthalmology (1984) 3.64

Warning signals from Oregon. BMJ (1992) 3.58

Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell (2000) 3.54

Towards a new pluralism. Health Policy (1987) 3.47

Diabetic retinopathy. Diabetes Care (1998) 3.39

Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest (1982) 3.33

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31

Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet (2001) 3.28

Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology (1985) 3.20

Rationing in practice: the case of in vitro fertilisation. BMJ (1993) 3.20

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med (1994) 3.20

Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell (1996) 3.19

Priorities and rationing: pragmatism or principles? BMJ (1995) 3.09

An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet (1985) 3.03

trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell (1991) 2.97

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care (1998) 2.97

Ten-year incidence of visual loss in a diabetic population. Ophthalmology (1994) 2.91

Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89

Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. J Am Geriatr Soc (1998) 2.88

Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80

The politics of change. BMJ (1991) 2.70

Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology (1992) 2.68

Puzzling out priorities. Why we must acknowledge that rationing is a political process. BMJ (1998) 2.65

Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1992) 2.55

Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology (1998) 2.50

Is the English NHS underfunded? BMJ (1999) 2.47

Association of NIDDM and hearing loss. Diabetes Care (1998) 2.45

The GlideScope Video Laryngoscope: randomized clinical trial in 200 patients. Br J Anaesth (2004) 2.41

Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science (1997) 2.40

Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol (1994) 2.39

Controlling the gatekeepers: the accountability of general practitioners. J R Coll Gen Pract (1986) 2.39

Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36

From evidence-based medicine to evidence-based policy? J Health Serv Res Policy (2000) 2.36

Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA (1999) 2.35

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology (1991) 2.34

The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (1999) 2.33

On the way to Calvary. Ministers should realise the command and control model the white paper entails. BMJ (1998) 2.30

Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia (1995) 2.27

Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J (1996) 2.26

Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J Virol (1982) 2.26

Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology (1985) 2.26

Why Britain is reorganizing its national health service--yet again. Health Aff (Millwood) (1998) 2.25

Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol (1994) 2.23

Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care (2001) 2.16

A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature (1997) 2.16

The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol (1991) 2.14

Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell (1996) 2.14

Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost (2013) 2.13

Dietary fat and age-related maculopathy. Arch Ophthalmol (1995) 2.11

A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr (1993) 2.06

Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron (2001) 2.06

Incomes: vive la différence. Br Med J (1976) 2.03

Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (1999) 2.01

Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron (1993) 2.01

Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1987) 1.99

The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell (1991) 1.97

The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell (2001) 1.88

Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology (1995) 1.86

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med (2000) 1.86

Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev (2001) 1.83

Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol (1993) 1.81

EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron (1999) 1.81

A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens (2011) 1.81

Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med (1993) 1.80

The Onchocerciasis Elimination Program for the Americas: a history of partnership. Rev Panam Salud Publica (1998) 1.79

Accuracy of self-reported hearing loss. Audiology (1998) 1.77

Lessons from the financial scandals in Wessex and the West Midlands. BMJ (1994) 1.76